Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators aimed to evaluate the effect of AMCPR (Augmented-Medication CardioPulmonary Resuscitation: administration of additional vasopressin to titrate to arterial diastolic blood pressure over 20 mmHg) on cardiopulmonary resuscitation results and outcomes in out-of-hospital cardiac arrest patients.
Non-traumatic out-of-hospital cardiac arrest patients receive standard advanced cardiac life support according to the 2015 AHA guideline, including chest compression, intubation, ventilation, defibrillation, drug administration, including epinephrine and antiarrhythmic drugs if indicated, in the emergency department.
A research associate generates a random sequence using Excel software, and assignment of participants to their respective groups will be undertaken by the principal investigator.
Arterial line insertion is performed within 6 minutes after randomization and diastolic blood pressure will be monitored.
If diastolic blood pressure is < 20 mmHg, drugs (vasopressin 40 IU or normal saline) will be administered for two times during CPR.
Arterial blood gas analysis will be analyzed for 5, 10, 15, and 20 minutes after arterial line insertion or termination of CPR.
End-tidal carbon dioxide concentrations is monitored in real time during CPR and recorded every minute.
The resuscitated patients receive standard post cardiac arrest care according to the 2015 AHA guideline.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Vasopressins | Experimental | Additional vasopressin 40 IU intravenous injection for 2 times |
|
| Normal saline | Placebo Comparator | Additional normal saline intravenous injection for 2 times |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Vasopressins | Drug | Administer additional vasopressin 40 IU IV for 2 times during cardiopulmonary resuscitation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Sustained return of spontaneous circulation (ROSC) | CPCR result Achievement of sustained ROSC was declared when patients had a palpable pulse for more than 20 minutes. | for 20 minutes after the time that participants had a palpable pulse |
| Measure | Description | Time Frame |
|---|---|---|
| Improvement of arterial diastolic blood pressure assessed by arterial line | Successful adult resuscitation is more likely when diastolic blood pressure is > 25 to 30 mmHg. The 2015 AHA Guidelines for CPR and ECC recommend "trying to improve quality of CPR by optimizing chest compression parameters or giving vasopressors or both" if diastolic blood pressure is <20 mmHg. Investigators will record the hemodynamic monitor in real-time. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Won Young Kim, MD, PhD | Asan Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chonnam National University Hospital | Gwangju | South Korea | ||||
| Asan Medical Center |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39952383 | Derived | Kim JS, Kim YJ, Hong SI, Kim SM, Chae B, Ryoo SM, Kim WY. Diastolic blood pressures and end tidal carbon dioxides during cardiopulmonary resuscitations and their association with outcomes in adult out-of-hospital cardiac arrest patients: A preplanned secondary analysis of the Augmented Medication CardioPulmonary resuscitation (AMCPR) trial. Resuscitation. 2025 May;210:110537. doi: 10.1016/j.resuscitation.2025.110537. Epub 2025 Feb 12. | |
| 36318879 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D058687 | Out-of-Hospital Cardiac Arrest |
| D003919 | Diabetes Insipidus |
| ID | Term |
|---|---|
| D006323 | Heart Arrest |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D007674 | Kidney Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D014667 | Vasopressins |
| D000077330 | Saline Solution |
| D012965 | Sodium Chloride |
| ID | Term |
|---|---|
| D010909 | Pituitary Hormones, Posterior |
| D010907 | Pituitary Hormones |
| D036361 | Peptide Hormones |
| D006728 | Hormones |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Normal saline | Drug | Placebo |
|
|
| during CPR, every 10 seconds after arterial line insertion until the termination of CPR due to ROSC or death, whichever came first, assessed up to 30 minutes |
| Improvement of end-tidal carbon dioxide concentrations assessed by capnography | End-tidal carbon dioxide concentrations during CPR are primarily dependent on pulmonary blood flow and therefore reflect cardiac output. Failure to maintain end-tidal carbon dioxide concentrations > 10 mmHg during adult CPR reflects poor cardiac output and strongly predicts unsuccessful resuscitation. Investigators will record the end-tidal carbon dioxide concentrations in real-time. | during CPR, every one minute after endotracheal tube insertion until the termination of CPR due to ROSC or death, whichever came first, assessed up to 30 minutes |
| Improvement of acid-base status measured by blood-gas analysis | Data are insufficient to make a conclusions, acid-base status can reflect the status of the ischemic insult on a cellular level. The changed of acid-base status during CPR may be associated with outcomes in cardiac arrest patients. | during CPR, 5, 10, 15, and 20 minute after arterial line insertion and termination of CPR |
| Improvement of lactate level measured by blood-gas analysis | In previous studies, low lactate level was prognostic factors for favourable outcome after sustained ROSC. Lactate level can reflect the status of the ischemic insult on a cellular level. | during CPR, 5, 10, 15, and 20 minute after arterial line insertion and termination of CPR |
| Low level of neuron specific enolase level | Low level of neuron specific enolase level is known as a prognostic indicator of neurologic outcome after cardiac arrest. | 24, 48, and 72 hours after ROSC |
| Good neurological outcome based on Cerebral Performance Categories Scale | CPC 1. Good cerebral performance: conscious, alert, able to work, might have mild neurologic or psychologic deficit. CPC 2. Moderate cerebral disability: conscious, sufficient cerebral function for independent activities of daily life. CPC 3. Severe cerebral disability: conscious, dependent on others for daily support because of impaired brain function. CPC 4. Coma or vegetative state: any degree of coma without the presence of all brain death criteria. CPC 5. Brain death: apnea, areflexia, EEG silence, etc. Good neurologic outcome is defined as CPC 1 and 2. | checked at hospital discharge (participants will be followed for duration of hospital stay, an expected average of 4 weeks) |
| Seoul |
| 05505 |
| South Korea |
| Derived |
| Oh DK, Kim JS, Ryoo SM, Kim YJ, Kim SM, Hong SI, Chae B, Kim WY. Augmented-Medication CardioPulmonary Resuscitation (AMCPR) trial: a study protocol for a randomized controlled trial. Clin Exp Emerg Med. 2022 Dec;9(4):361-366. doi: 10.15441/ceem.22.367. Epub 2022 Nov 2. |
| D014570 |
| Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D010900 | Pituitary Diseases |
| D004700 | Endocrine System Diseases |
| D006730 |
| Hormones, Hormone Substitutes, and Hormone Antagonists |
| D009479 | Neuropeptides |
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |
| D009842 | Oligopeptides |
| D009419 | Nerve Tissue Proteins |
| D011506 | Proteins |
| D000077324 | Crystalloid Solutions |
| D007552 | Isotonic Solutions |
| D012996 | Solutions |
| D004364 | Pharmaceutical Preparations |
| D002712 | Chlorides |
| D006851 | Hydrochloric Acid |
| D017606 | Chlorine Compounds |
| D007287 | Inorganic Chemicals |
| D017670 | Sodium Compounds |